Antitrust Merial and Intervet/Schering-Plough terminate agreement

US-based Merck and France based sanofi-aventis have terminated their agreement to form a new animal health joint venture by combining sanofi-aventis’ animal health business Merial with Intervet/Schering-Plough, Merck's animal health unit. As a result, each party will keep its current, separate animal health assets and businesses.

Since the initial announcement about the intended combination on March 9, 2010, both companies have worked diligently to create the proposed animal health joint venture, including submitting requests for the required antitrust reviews. Read more ...

This blog is written by Martin Little The Global Miller, published and supported by the GFMT Magazine from Perendale Publishers.